CCDC134, a novel secretory protein, inhibits activation of ERK and JNK, but not p38 MAPK

被引:25
|
作者
Huang, J. [1 ,2 ]
Shi, T. [1 ,2 ,3 ]
Ma, T. [1 ,2 ]
Zhang, Y. [1 ,2 ]
Ma, X. [1 ,2 ]
Lu, Y. [3 ]
Song, Q. [1 ,2 ]
Liu, W. [1 ,2 ]
Ma, D. [1 ,2 ,3 ]
Qiu, X. [1 ,2 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Lab Med Immunol, Beijing 100871, Peoples R China
[2] Peking Univ, Human Dis Gen Ctr, Beijing 100083, Peoples R China
[3] Chinese Natl Human Genome Ctr, Beijing, Peoples R China
关键词
CCDC134; secretory protein; inhibit; Elk1; MAPK pathway;
D O I
10.1007/s00018-007-7448-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we report a novel gene, CCDC134 (coiled-coil domain containing 134), that encodes a secretory protein that can inhibit the MAPK pathway as a novel human MAPK-regulating protein. The CCDC134 mRNA contains 1280 nucleotides, encoding a protein of 229 amino acids. CCDC134 is a classical secretory protein. Expression profile analysis by Northern blot, RT-PCR, immunohistochemistry and Western blot reveals that CCDC134 is widely expressed in normal adult tissues, tumor tissues and cell lines. Functional investigation reveals that overexpression of CCDC134 and its purified protein significantly inhibit transcriptional activity of Elk1 and phosphorylation of Erk and JNK/SAPK but not p38 MAPK. Conversely, specific siRNA against CCDC134 activates Elk1 transcriptional activity and promotes Erk and JNK/SAPK phosphorylation. These results clearly indicate that CCDC134 is a novel member of the secretory family and down-regulates the Raf-1/MEK/ERK and JNK/ SAPK pathways.
引用
收藏
页码:338 / 349
页数:12
相关论文
共 50 条
  • [31] Phosphorylated p38 and JNK MAPK proteins in hepatocellular carcinoma
    Wang, Shen-Nien
    Lee, King-Teh
    Tsai, Chia-Jung
    Chen, Yu-Jie
    Yeh, Yao-Tsung
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (12) : 1295 - 1301
  • [32] NSAIDs inhibit p38 MAPK activation
    Cheryl Smythe
    [J]. Arthritis Research & Therapy, 4 (1)
  • [33] TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway
    Mengying Xing
    Ying Yang
    Jiaxue Huang
    Yaqun Fang
    Yucui Jin
    Lingyun Li
    Xiang Chen
    Xiaoxia Zhu
    Changyan Ma
    [J]. Genes & Genomics, 2022, 44 : 801 - 812
  • [34] TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway
    Xing, Mengying
    Yang, Ying
    Huang, Jiaxue
    Fang, Yaqun
    Jin, Yucui
    Li, Lingyun
    Chen, Xiang
    Zhu, Xiaoxia
    Ma, Changyan
    [J]. GENES & GENOMICS, 2022, 44 (07) : 801 - 812
  • [35] Increased activation of p38 MAPK in COPD
    Renda, T.
    Baraldo, S.
    Pelaia, G.
    Bazzan, E.
    Turato, G.
    Papi, A.
    Maestrelli, P.
    Maselli, R.
    Vatrella, A.
    Fabbri, L. M.
    Zuin, R.
    Marsico, S. A.
    Saetta, M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (01) : 62 - 69
  • [36] Effect of TEGDMA on the activation of p38 and ERK
    Eckhardt, A.
    Gerstmayr, N.
    Hiller, K. -A
    Bolay, C.
    Schmalz, G.
    Schweikl, H.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 86 - 86
  • [37] Acetaldehyde induces tau phosphorylation via activation of p38 MAPK/JNK and ROS production
    Tingting Li
    Huahua Shi
    Yan Zhao
    [J]. Molecular & Cellular Toxicology, 2022, 18 : 311 - 320
  • [38] Combination of Everolimus and Bortezomib Inhibits the Growth and Metastasis of Bone and Soft Tissue Sarcomas via JNK/p38/ERK MAPK and AKT Pathways
    Nakamura, Koichi
    Asanuma, Kunihiro
    Okamoto, Takayuki
    Iino, Takahiro
    Hagi, Tomohito
    Nakamura, Tomoki
    Sudo, Akihiro
    [J]. CANCERS, 2023, 15 (09)
  • [39] Neferine induces apoptosis of pancreatic cancer cells through p38 MAPK/JNK activation
    Feng, Tielan
    Chen, Hao
    Peng, Yaofang
    Sun, Xiaoming
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (08) : 1615 - 1619
  • [40] MKP-8, a novel MAPK phosphatase that inhibits p38 kinase
    Vasudevan, SA
    Skoko, J
    Wang, K
    Burlingame, SM
    Patel, PN
    Lazo, JS
    Nuchtern, JG
    Yang, JH
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 330 (02) : 511 - 518